Tharimmune

Historical price data

Canton Strategic Holdings, Inc. (formerly Tharimmune) is a publicly traded company that has strategically shifted its core mission from biotechnology to financial infrastructure. The company's primary objective is to leverage the Canton Network, a privacy-enabled public blockchain, to drive the tokenization of real-world assets and digitize financial markets. Its strategy involves operating a Super Validator on the network, investing in network-supporting activities, and leveraging a management team with deep institutional finance and technology expertise to capture value in the evolving digital asset ecosystem.

Operates a Super Validator and invests in activities supporting the Canton Network, a privacy-enabled public blockchain designed for institutional financial applications and real-world asset tokenization.

Competes with other institutional blockchain networks (e.g., Ethereum L2s, Corda), private validator/staking businesses, and traditional financial infrastructure providers. Its differentiation is its exclusive public company focus on the Canton Network and its management's deep institutional finance expertise.